Sean Ekins and Fabio Urbina, two Collaborations scientists, decided to tweak their drug discovery platform to see what results they might produce. The platform was reprogramed to generate VX, one of the deadliest and fastest-acting chemical warfare nerve agents.
Read More
Over the last several months, Raleigh-based Collaborations Pharmaceuticals has obtained funding from two research arms of the National Institutes of Health to support its machine learning applications in drug discovery research.
Read More
NC TECH announced recently the slate of six startups selected to present as part of the 2020 Startup Showcase at the State of Technology Conference on the mornings of July 23 and 24. Here’s a look at each.
Read More
The Raleigh-based startup is in the business of collaboration. It partners with the academic community, foundations and other companies to develop drugs that treat rare and neglected diseases. And COVID-19 is one of its targets.
Read More
